Journal Newsview all

Friday, February 27, 2015 | Source: American Journal of Cardiology

IVUS Guidance of PCI May Lower In-Hospital Mortality vs Angiography

By Todd Neale

IVUS-guided PCI is associated with a lower in-hospital mortality risk but slightly higher costs and complication rates than angiography, according…

Friday, February 27, 2015 | Source: Journal of the American College of Cardiology

EVERBIO II Published: BVS Matches Leading DES for Midterm Outcomes

By L.A. McKeown

In an all-comers population with significant ACS and complex lesions, bioresorbable vascular scaffolds (BVS) perform as well as best-in-class DES…

Thursday, February 26, 2015 | Source: Circulation

Both Dosing Safety, Guideline-Based Use of Antithrombotics Related to NSTE-ACS Outcomes

By Yael L. Maxwell

Hospitals vary widely in their appropriate dosing of antithrombotics and adherence to guideline-recommended therapies for patients with NSTE-ACS,…

Wednesday, February 25, 2015 | Source: Stroke

Outcomes of Endovascular Therapy for Acute Ischemic Stroke Getting Better Over Time

By Todd Neale

In recent years, use of endovascular therapy for acute ischemic stroke has increased modestly as patient outcomes have improved, according to a…

Wednesday, February 25, 2015 | Source: Journal of Vascular Surgery

Rupture Rates in Patients With Untreated Large AAAs Lower Than Previously Thought

By Kim Dalton

The likelihood of rupture of untreated large abdominal aortic aneurysms (AAAs) in patients deemed unfit for elective repair is lower than that commonly…

Tuesday, February 24, 2015 | Source: Journal of the American College of Cardiology

ZEUS Published: ZES With Personalized DAPT Bests Bare-Metal Stent in ‘Uncertain’ DES Candidates

By L.A. McKeown

Patients at high risk of bleeding or thrombosis and/or low risk of restenosis who are considered uncertain candidates for DES have fewer major adverse…

Tuesday, February 24, 2015 | Source: Journal of the American Medical Association

Concomitant NSAID, Antithrombotic Therapy Increases Bleeding, CV Events After MI

By Yael L. Maxwell

Among patients receiving antithrombotic therapy after MI, concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs) is linked to increased…

Monday, February 23, 2015 | Source: Journal of the American College of Cardiology

Survey Puts Spotlight on Physical Stress of Working in a Cath Lab

By Kim Dalton

Cath lab personnel who spend long hours wearing heavy lead aprons to protect against radiation exposure are more likely to experience musculoskeletal…

Monday, February 23, 2015 | Source: Circulation Research

Nitrite Injection May Be Cardioprotective in STEMI Patients With Low TIMI Flow

By Meghann Lucy

An intracoronary injection of nitrite during primary PCI does not reduce infarct size in STEMI patients, according to a small, randomized proof-of-concept…

Friday, February 20, 2015 | Source: Journal of the American Medical Association

Real-World Study Supports Fondaparinux Over Heparin for NSTEMI

By Todd Neale

Fondaparinux is associated with lower risks of severe bleeding and death compared with low-molecular-weight heparin (LMWH) in patients with NSTEMI…

Conference Newsview all

Monday, November 24, 2014 | Source: American Heart Association Scientific Sessions

AHA 2014: Much-Anticipated Large Trials Bring Some Surprises

By Kim Dalton
CHICAGO, IL—Preventive medical therapies, mostly given in the wake of percutaneous coronary intervention (PCI) with drug-eluting stents (DES), took center…
Wednesday, November 19, 2014 | Source: AHA 2014

AVOIDing Oxygen in Suspected STEMI Tied to Smaller Infarcts, Less Recurrent MI

By Yael L. Maxwell

CHICAGO, IL—Oxygen therapy has long been standard practice in patients with suspected ST-segment elevation myocardial infarction (STEMI), but results…

Wednesday, November 19, 2014 | Source: AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

By Kim Dalton

CHICAGO, IL—Two recent trials of biodegradable-polymer drug-eluting stents (DES) have failed to support the concept that eliminating a key substrate…

Wednesday, November 19, 2014 | Source: AHA 2014

Regional STEMI Care Systems Improve Treatment Times

By Yael L. Maxwell

CHICAGO, IL—Implementing a regional system of care for patients with ST-segment elevation myocardial infarction (STEMI) is vital to increasing the…

Tuesday, November 18, 2014 | Source: AHA 2014

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

By Yael L. Maxwell

CHICAGO, IL—Compared with clopidogrel treatment, prasugrel and—even more so—ticagrelor reduce the risk of stent thrombosis and mortality over 2 years…

Tuesday, November 18, 2014 | Source: AHA 2014

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

By Yael L. Maxwell

CHICAGO, IL—Adding surgical mitral valve repair to coronary artery bypass grafting (CABG) in patients with moderate ischemic mitral regurgitation…

Tuesday, November 18, 2014 | Source: AHA 2014

Role of CTA in Survival Prediction, Resource Utilization Explored

By Kim Dalton

CHICAGO, IL—While coronary computed tomographic angiography (CTA) has the ability to predict a period of low mortality risk in those with normal…

Tuesday, November 18, 2014 | Source: AHA 2014

Novel, Efficient CT-based FFR Outperforms CTA

By Kim Dalton

CHICAGO, IL—A new, more efficient method of computing fractional flow reserve (FFR) using data from computed tomographic angiography (CTA) not only…

Monday, November 17, 2014 | Source: AHA 2014

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

By Kim Dalton

CHICAGO, IL—A strategy of screening asymptomatic patients with diabetes with computed tomography angiography (CTA) and using the results to guide…

Monday, November 17, 2014 | Source: AHA 2014

Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery

By Yael L. Maxwell

CHICAGO, IL—In patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) who undergo noncardiac surgery, the novel antiplatelet agent…